Scarica l'app Stockscreener
0.9079
1.13%
-0.0104
Dopo l'orario di chiusura:
.91
0.0021
+0.23%
Precedente Chiudi:
$0.9183
Aprire:
$0.9053
Volume 24 ore:
1.65M
Relative Volume:
0.89
Capitalizzazione di mercato:
$354.15M
Reddito:
$105.90M
Utile/perdita netta:
$-61.49M
Rapporto P/E:
-4.604
EPS:
-0.1972
Flusso di cassa netto:
$-82.65M
1 W Prestazione:
-5.23%
1M Prestazione:
-17.46%
6M Prestazione:
-29.07%
1 anno Prestazione:
-23.06%
Intervallo 1D:
$0.8817
$0.9289
Intervallo di 1 settimana:
$0.88
$0.96
Portata 52W:
$0.88
$1.72
Standard Biotools Inc Stock (LAB) Company Profile
Nome
Standard Biotools Inc
Settore
Industria
Telefono
(650) 266-6000
Indirizzo
50 MILK STREET, BOSTON
Compare LAB vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
0.9079 | 354.15M | 105.90M | -61.49M | -82.65M | -0.1972 |
ABT
Abbott Laboratories
|
102.87 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
331.54 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.63 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.82 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.05 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-13 | Downgrade | TD Cowen | Buy → Hold |
| 2025-02-27 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | Iniziato | TD Cowen | Buy |
| 2024-04-04 | Iniziato | Jefferies | Buy |
| 2023-07-12 | Iniziato | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Borsa (LAB) Ultime notizie
Standard BioTools (LAB) Price Target Decreased by 12.68% to 1.58 - MSN
LAB SEC FilingsSTANDARD BIOTOOLS INC 10-K, 10-Q, 8-K Forms - Stock Titan
Can Standard BioTools Inc scale operations efficiently2026 Big Picture & Detailed Earnings Play Strategies - baoquankhu1.vn
Growth Value: Is Standard BioTools Inc impacted by rising rates2026 Catalysts & Safe Capital Preservation Plans - baoquankhu1.vn
Standard BioTools Inc (LAB) Stock Price Quote Today & Current Price Chart - Capital.com
Short Interest in Standard BioTools Inc. (NASDAQ:LAB) Declines By 18.5% - MarketBeat
Can Standard BioTools Inc stock double in the next yearCEO Change & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Downgrade Watch: Will Standard BioTools Inc stock hit new highs in YEAR2026 Fed Impact & High Return Trade Opportunity Guides - baoquankhu1.vn
Analysis Recap: Is Standard BioTools Inc impacted by rising rates2026 Sentiment & Risk Managed Investment Entry Signals - baoquankhu1.vn
Earnings Risk: Is Standard BioTools Inc impacted by rising rates2026 Key Lessons & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Standard BioTools (NASDAQ:LAB) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Pullback Watch: Does Standard BioTools Inc have declining or rising EPSMarket Sentiment Summary & Weekly Return Optimization Plans - baoquankhu1.vn
Whale Trades: Can Standard BioTools Inc stock double in the next yearGDP Growth & Safe Entry Momentum Tips - baoquankhu1.vn
Long Focus Capital Management LLC Acquires 1,292,804 Shares of Standard BioTools Inc. $LAB - MarketBeat
Standard BioTools Inc. $LAB Shares Purchased by Mak Capital One LLC - MarketBeat
Standard BioTools Inc. 2025 Annual Report: Market Overview, Innovation, and Regulatory Landscape in Life Sciences Tools - Minichart
Standard BioTools 2025 10-K: Revenue $85.3M, EPS $(0.20) - TradingView
Standard BioTools (NASDAQ: LAB) refocuses on core tools after SomaScan sale - Stock Titan
Standard BioTools Inc. $LAB Stake Boosted by Casdin Capital LLC - MarketBeat
Shorts Report: Can Standard BioTools Inc grow without dilution2026 Trading Recap & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Standard BioTools (NASDAQ:LAB) Cut to "Sell" at Wall Street Zen - MarketBeat
Retail Trends: Will Standard BioTools Inc stock hit new highs in YEARWeekly Market Report & Fast Momentum Entry Tips - baoquankhu1.vn
Does Standard BioTools Inc have declining or rising EPSJuly 2025 Chart Watch & Fast Momentum Entry Tips - baoquankhu1.vn
Aug PostEarnings: Should I invest in Standard BioTools Inc before earningsQuarterly Trade Summary & Expert Verified Movement Alerts - baoquankhu1.vn
LAB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
LAB Technical Analysis & ETF Price Forecast - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Eli Casdin boosts equity stake in STANDARD BIOTOOLS (LAB) with 52,991 RSUs - Stock Titan
STANDARD BIOTOOLS (LAB) director takes 51,282 RSUs in lieu of $60K cash - Stock Titan
Retail Trends: Is Standard BioTools Inc a strong growth stockJuly 2025 Analyst Calls & Weekly High Return Opportunities - baoquankhu1.vn
Director at Standard BioTools (LAB) takes RSUs instead of cash pay - Stock Titan
Standard BioTools (NASDAQ:LAB) Upgraded to Hold at Wall Street Zen - marketbeat.com
Standard BioTools Inc. (LAB) Stock Analysis: Unveiling a 32% Upside Potential Amidst Challenging Metrics - DirectorsTalk Interviews
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Globus Medical (GMED), Standard BioTools (LAB) and Addus Homecare (ADUS) - The Globe and Mail
Standard BioTools (LAB) Q4 Profit Challenges Longstanding Unprofitable Narrative - Sahm
Standard BioTools Q4 2025 Results: Profit on $23.8M RevenueNews and Statistics - IndexBox
Standard BioTools Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Standard BioTools (LAB) Reports Strong Q4 Revenue Exceeding Expe - GuruFocus
Standard BioTools Inc (NASDAQ:LAB) Surges on Strong Q4 Earnings Beat - ChartMill
STANDARD BIOTOOLS (LAB) CEO has shares withheld to cover RSU tax bill - Stock Titan
Standard BioTools (LAB) SVP disposes shares for tax withholding - Stock Titan
Tax withholding trims Standard BioTools (LAB) CFO share stake - Stock Titan
Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results - Investing News Network
Standard Biotools earnings beat by $0.10, revenue topped estimates - Investing.com Canada
Standard BioTools Details SomaLogic Sale and Profitability Path - TipRanks
LAB Forecasts Revenue Between $80 Million and $85 Million for FY - GuruFocus
Standard BioTools: Q4 Earnings Snapshot - marketscreener.com
Standard BioTools (NASDAQ:LAB) Announces Earnings Results - MarketBeat
Standard BioTools Q4 Earnings Report: What Investors Need to Know - Benzinga
Preview: Standard BioTools's Earnings - Benzinga
LABSTANDARD BIOTOOLS INC Latest Stock News & Market Updates - Stock Titan
Standard Biotools Inc Azioni (LAB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):